VIR in the 13F filings
Vir Biotechnology Inc · CUSIP 92764N102
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 10 Feb 2026
- Managers listing it
- 25
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 0 listed it in both
- Shares listed
- 12,032,213
- combined, among listed positions
- Reported value
- $73m
- combined, at the quarter end
Among the 92 comparable managers: 15 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +489,600.
Managers listing VIR in Q4 2025
25 of 25 holders
Largest increases and reductions, by shares
Increases
- Balyasny Asset Management LLCnew position · 1,368,474 shares now+1,368,474
- Hudson Bay Capital Management LPexisting position · 1,325,000 shares now+413,118
- Point72 Asset Management LPnew position · 195,718 shares now+195,718
- Jane Street Group LLCexisting position · 264,006 shares now+191,766
- Winton Group Ltdexisting position · 189,306 shares now+131,555
Reductions
- Renaissance Technologies LLCexisting position · 614,464 shares now-552,636
- Fidelity (FMR LLC)existing position · 3,158,416 shares now-478,714
- Millennium Management LLCexisting position · 1,002,606 shares now-393,898
- Citadel Advisors LLCexisting position · 489,226 shares now-309,808
- Squarepoint Ops LLCexisting position · 20,867 shares now-256,448
New positions and exits
New (4)
Exited (2)
- Man Group PLCwas $402k
- Quantbot Technologies LPwas $83k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2019 | 1 | $6.3m | n.a. | n.a. |
| Q1 2020 | 1 | $4.5m | n.a. | n.a. |
| Q2 2020 | 3 | $223m | n.a. | n.a. |
| Q3 2020 | 2 | $199m | n.a. | n.a. |
| Q4 2020 | 3 | $189m | n.a. | n.a. |
| Q1 2021 | 3 | $302m | n.a. | n.a. |
| Q2 2021 | 3 | $292m | n.a. | n.a. |
| Q3 2021 | 3 | $272m | n.a. | n.a. |
| Q4 2021 | 4 | $375m | n.a. | n.a. |
| Q1 2022 | 3 | $303m | n.a. | n.a. |
| Q2 2022 | 4 | $176m | n.a. | n.a. |
| Q3 2022 | 4 | $111m | n.a. | n.a. |
| Q4 2022 | 2 | $102m | n.a. | n.a. |
| Q1 2023 | 4 | $198m | n.a. | n.a. |
| Q2 2023 | 5 | $189m | n.a. | n.a. |
| Q3 2023 | 2 | $39m | n.a. | n.a. |
| Q4 2023 | 2 | $43m | 1 | 1 |
| Q1 2024 | 3 | $44m | 1 | 2 |
| Q2 2024 | 5 | $42m | 4 | 1 |
| Q3 2024 | 5 | $25m | 4 | 1 |
| Q4 2024 | 4 | $14m | 2 | 2 |
| Q1 2025 | 1 | $5.1m | 0 | 1 |
| Q2 2025 | 1 | $4.0m | 0 | 0 |
| Q4 2025 | 2 | $9.1m | 15 | 10 |
| Q1 2026 | 3 | $17m | 18 | 10 |
| Q2 2026 | 3 | $73m | 12 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
VIR and GILD →VIR and AMGN →VIR and ARGX →Choose a stock to compare with VIR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own VIR, latest filings →Back to the 13F Explorer →